Fcp, let me reiterate again, Mr. Han Yanhua is the Chairman of the Board holding 14,875,000 shares or 29.75% of all the 50,000,000 common shares, therefore Han is in control here. CEO's can be replaced but not the COB without selling ownership of their company. Mr. Hu Xiayang doesn't own Biopharm Asia but rather works for the company, and his main goal is to get it running smoothly to make Han happy. Albeit, Han is not pleased with the low value of his shares as are the other 4 large investment groups consisting of: Giant Fortune Investment Management limited with 2M shares; Enhanced Way Investments Limited; Power Step Investment Limited, and Talent Peak Limited, with all the last three owning 4.25M shares respectively.
Rec
